NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 16.39 -0.65 (3.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.04 | 52 Week High | $9.54 | |||
| Open | $16.89 | 52 Week Low | $5.49 | |||
| Day High | $17.17 | P/E | 409.75 | |||
| Day Low | $16.13 | EPS | $0.04 | |||
| Volume | 2,463,370 | |||||
